New findings reported from Harvard University describe advances in medicare and medicaid

Current study results from the report, 'State payer mandates to cover care in US oncology trials: do science and ethics matter,' have been published. "In the United States, Medicare-eligible participants' costs for routine care and complications from cancer clinical trials are covered by Medicare, but other people depend on state insurance mandates to assure coverage. State mandates were reviewed for requirements to assure trials' scientific and ethical soundness, whom they covered and omitted, scope, and coverage for participants' research-related injuries in addition to routine care costs," scientists writing in the journal JNCI Cancer Spectrum report.

...

Want to see the full article?

• Purchase this article for only $3.00